1. Home
  2. IH vs TLSA Comparison

IH vs TLSA Comparison

Compare IH & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.98

Market Cap

116.0M

Sector

Real Estate

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.22

Market Cap

166.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
TLSA
Founded
1996
2013
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
166.7M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
IH
TLSA
Price
$1.98
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.3K
93.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$0.73
52 Week High
$3.60
$2.60

Technical Indicators

Market Signals
Indicator
IH
TLSA
Relative Strength Index (RSI) 42.17 34.79
Support Level $1.74 N/A
Resistance Level $2.29 $1.56
Average True Range (ATR) 0.11 0.10
MACD 0.01 -0.01
Stochastic Oscillator 23.68 5.41

Price Performance

Historical Comparison
IH
TLSA

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: